4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-22-028159
Sr. VP and CFO acquired 121,951 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rubin Eyal Sr. VP and CFO | 2022-02-25 | Grant or award | +121,951 | 368,097 | I |
Loading xslF345X03/tm227910-2_4seq1.xml…